Producing generics of OTC drug brands isn't enough for Perrigo Co. PLC any longer as it targets bigger growth and expects to get there marketing branded drugs, including developing its own Rx-to-OTC switches.
Perrigo Pegs Growth To Initiating OTC Switches, Not Following Brands' NDAs
"A foundation of this business has been," says Perrigo's Americas consumer business chief, Jeffrey Needham, "we are a fast follower. That's been our traditional model. We can't afford to do that going forward." In addition to initiating moving ingredients from Rx to OTC, firm is developing "national better brand" versions of drugs already available OTC.
